117 related articles for article (PubMed ID: 11839663)
1. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.
Inagawa S; Itabashi M; Adachi S; Kawamoto T; Hori M; Shimazaki J; Yoshimi F; Fukao K
Clin Cancer Res; 2002 Feb; 8(2):450-6. PubMed ID: 11839663
[TBL] [Abstract][Full Text] [Related]
2. Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
Am J Pathol; 2004 May; 164(5):1739-49. PubMed ID: 15111320
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis.
Chen J; Liu J; Jin R; Shen J; Liang Y; Ma R; Lin H; Liang X; Yu H; Cai X
PLoS One; 2014; 9(11):e111885. PubMed ID: 25401330
[TBL] [Abstract][Full Text] [Related]
4. Survivin, β-catenin, and ki-67 immunohistochemical expression in canine perivascular wall tumors: Preliminary assessment of prognostic significance.
Godizzi F; Armando F; Boracchi P; Avallone G; Stefanello D; Ferrari R; Chiti LE; Cappelleri A; Zamboni C; Dell'Aere S; Corradi A; Roccabianca P
Vet Pathol; 2024 May; ():3009858241246981. PubMed ID: 38727195
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of c-Met, β-catenin and FAK in patients with hepatocellular carcinoma following surgery.
Gong XY; Ma N; Xu HX; Chen F; Huang XH; Wang Q
Oncol Lett; 2018 Mar; 15(3):3796-3805. PubMed ID: 29467897
[TBL] [Abstract][Full Text] [Related]
6. Expression of beta-catenin in hepatocellular carcinoma.
Tien LT; Ito M; Nakao M; Niino D; Serik M; Nakashima M; Wen CY; Yatsuhashi H; Ishibashi H
World J Gastroenterol; 2005 Apr; 11(16):2398-401. PubMed ID: 15832407
[TBL] [Abstract][Full Text] [Related]
7. Beta-catenin expression in hepatocellular carcinoma: a possible participation of beta-catenin in the dedifferentiation process.
Suzuki T; Yano H; Nakashima Y; Nakashima O; Kojiro M
J Gastroenterol Hepatol; 2002 Sep; 17(9):994-1000. PubMed ID: 12167121
[TBL] [Abstract][Full Text] [Related]
8. Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia.
Suarez M I; Uribe D; Jaramillo CM; Osorio G; Perez JC; Lopez R; Hoyos S; Hainaut P; Pineau P; Navas MC
Ann Hepatol; 2015; 14(1):64-74. PubMed ID: 25536643
[TBL] [Abstract][Full Text] [Related]
9. Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology.
Cavard C; Colnot S; Audard V; Benhamouche S; Finzi L; Torre C; Grimber G; Godard C; Terris B; Perret C
Future Oncol; 2008 Oct; 4(5):647-60. PubMed ID: 18922122
[TBL] [Abstract][Full Text] [Related]
10. A combined bioinformatics and experimental approach identifies RMI2 as a Wnt/β-catenin signaling target gene related to hepatocellular carcinoma.
Tsai HW; Cheng SW; Chen CC; Chen IW; Ho CL
BMC Cancer; 2023 Oct; 23(1):1025. PubMed ID: 37875822
[TBL] [Abstract][Full Text] [Related]
11. Advances in Immunotherapy for Hepatocellular Carcinoma.
Hagiwara S; Nishida N; Kudo M
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046727
[TBL] [Abstract][Full Text] [Related]
12. Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma.
Leung RWH; Lee TKW
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358885
[TBL] [Abstract][Full Text] [Related]
13. Predicting liver cancer on epigenomics data using machine learning.
Vekariya V; Passi K; Jain CK
Front Bioinform; 2022; 2():954529. PubMed ID: 36304318
[TBL] [Abstract][Full Text] [Related]
14. An immune-inflamed tumor microenvironment as defined by CD8 score is associated with favorable oncologic outcomes in hepatocellular carcinoma independent of measures of tumor mutational burden.
Cherkassky L; Oshi M; Abdelfatah E; Wu R; Takabe Y; Yan L; Endo I; Takabe K
Am J Cancer Res; 2022; 12(7):3099-3110. PubMed ID: 35968349
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma.
Alonso-Peña M; Sanchez-Martin A; Sanchon-Sanchez P; Soto-Muñiz M; Espinosa-Escudero R; Marin JJG
Cancer Drug Resist; 2019; 2(3):680-709. PubMed ID: 35582588
[TBL] [Abstract][Full Text] [Related]
16. Target Therapy for Hepatocellular Carcinoma: Beyond Receptor Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors.
Park H; Park H; Baek J; Moon H; Ro SW
Biology (Basel); 2022 Apr; 11(4):. PubMed ID: 35453784
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of the Duality of Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma.
Aoki T; Nishida N; Kudo M
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053606
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA XIST accelerates hepatic carcinoma progression by targeting the microRNA-320a/PIK3CA axis.
Yang L; Xie F; Xu W; Xu T; Ni Y; Tao X; Zang Y; Jin J
Oncol Lett; 2021 Nov; 22(5):801. PubMed ID: 34630708
[TBL] [Abstract][Full Text] [Related]
19. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.
Morra A; Escala-Garcia M; Beesley J; Keeman R; Canisius S; Ahearn TU; Andrulis IL; Anton-Culver H; Arndt V; Auer PL; Augustinsson A; Beane Freeman LE; Becher H; Beckmann MW; Behrens S; Bojesen SE; Bolla MK; Brenner H; Brüning T; Buys SS; Caan B; Campa D; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Cheng TD; Clarke CL; ; Colonna SV; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Dennis J; Dörk T; Dossus L; Dunning AM; Dwek M; Eccles DM; Ekici AB; Eliassen AH; Eriksson M; Evans DG; Fasching PA; Flyger H; Fritschi L; Gago-Dominguez M; García-Sáenz JA; Giles GG; Grip M; Guénel P; Gündert M; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Hart SN; Hartikainen JM; Hartmann A; He W; Hooning MJ; Hoppe R; Hopper JL; Howell A; Hunter DJ; ; ; Jager A; Jakubowska A; Janni W; John EM; Jung AY; Kaaks R; Keupers M; Kitahara CM; Koutros S; Kraft P; Kristensen VN; Kurian AW; Lacey JV; Lambrechts D; Le Marchand L; Lindblom A; Linet M; Luben RN; Lubiński J; Lush M; Mannermaa A; Manoochehri M; Margolin S; Martens JWM; Martinez ME; Mavroudis D; Michailidou K; Milne RL; Mulligan AM; Muranen TA; Nevanlinna H; Newman WG; Nielsen SF; Nordestgaard BG; Olshan AF; Olsson H; Orr N; Park-Simon TW; Patel AV; Peissel B; Peterlongo P; Plaseska-Karanfilska D; Prajzendanc K; Prentice R; Presneau N; Rack B; Rennert G; Rennert HS; Rhenius V; Romero A; Roylance R; Ruebner M; Saloustros E; Sawyer EJ; Schmutzler RK; Schneeweiss A; Scott C; Shah M; Smichkoska S; Southey MC; Stone J; Surowy H; Swerdlow AJ; Tamimi RM; Tapper WJ; Teras LR; Terry MB; Tollenaar RAEM; Tomlinson I; Troester MA; Truong T; Vachon CM; Wang Q; Hurson AN; Winqvist R; Wolk A; Ziogas A; Brauch H; García-Closas M; Pharoah PDP; Easton DF; Chenevix-Trench G; Schmidt MK
Breast Cancer Res; 2021 Aug; 23(1):86. PubMed ID: 34407845
[TBL] [Abstract][Full Text] [Related]
20. Anticancer effects of Poncirus fructus on hepatocellular carcinoma through regulation of apoptosis, migration, and invasion.
Munakarmi S; Chand L; Shin HB; Hussein UK; Yun BS; Park HR; Jeong YJ
Oncol Rep; 2020 Dec; 44(6):2537-2546. PubMed ID: 33125135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
